Author Steinacker, Petra

• 2000 | Journal Article
  ​ ​Decreased beta-amyloid(1-42) in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease​
  Otto, M.; Esselmann, H. ; Schulz-Schaeffer, W. J.; Neumann, M.; Schroter, A.; Ratzka, P. & Cepek, L. et al.​ (2000) 
  Neurology, 54(5) pp. 1099​-1102​.​
  ​Details  PMID  PMC  WoS 

• 2000 | Journal Article
  ​ ​The plasma membrane of Xenopus laevis oocytes contains voltage-dependent anion-selective porin channels​
  Steinacker, P.; Awni, L. A.; Becker, S.; Cole, T.; Reymann, S.; Hesse, D. & Kratzin, H. D. et al.​ (2000) 
  The International Journal of Biochemistry & Cell Biology, 32(2) pp. 225​-234​.​ DOI: https://doi.org/10.1016/S1357-2725(99)00124-7 
  ​Details  DOI  PMID  PMC  WoS 

• 2003 | Journal Article
  ​ ​Different binding pattern of antibodies to prion protein on lymphocytes from patients with sporadic Creutzfeldt–Jakob disease​
  Ratzka, P.; Döhlinger, S.; Cepek, L.; Steinacker, P.; Arlt, S.; Jacobi, C. & Schröter, A. et al.​ (2003) 
  Neuroscience Letters, 343(1) pp. 29​-32​.​ DOI: https://doi.org/10.1016/S0304-3940(03)00315-X 
  ​Details  DOI  PMID  PMC  WoS 

• 2003 | Journal Article
  ​ ​beta-Amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease​
  Wiltfang, J.; Esselmann, H.; Smirnov, A.; Bibl, M.; Cepek, L.; Steinacker, P. & Mollenhauer, B. et al.​ (2003) 
  Annals of Neurology, 54(2) pp. 263​-267​.​ DOI: https://doi.org/10.1002/ana.10661 
  ​Details  DOI  PMID  PMC  WoS 

• 2004 | Conference Abstract
  ​ ​Surface enhanced laser desorption/ionization time-of-flight mass spectrometry for the differential diagnosis of Creutzfeldt-Jakob disease​
  Steinacker, P.; Cepek, L.; Esselmann, H.; Kretzschmar, H. A.; Lewczuk, P.; Poser, S. & Wiltfang, J. et al.​ (2004)
  Neurobiology of Aging, 25 pp. S34​-S35. ​9th International Conference on Alzheimers Disease and Related Disorders​, Philadelphia, PA.
  New york​: Elsevier Science Inc. DOI: https://doi.org/10.1016/S0197-4580(04)80115-5 
  ​Details  DOI  WoS 

• 2004 | Journal Article
  ​ ​Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases​
  Steinacker, P.; Mollenhauer, B.; Bibl, M.; Cepek, L.; Esselmann, H.; Brechlin, P. & Lewczuk, P. et al.​ (2004) 
  Neuroscience Letters, 370(1) pp. 36​-39​.​ DOI: https://doi.org/10.1016/j.neulet.2004.07.061 
  ​Details  DOI  PMID  PMC  WoS 

• 2005 | Journal Article
  ​ ​Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease​
  Mollenhauer, B.; Bibl, M.; Trenkwalder, C.; Stiens, G.; Cepek, L.; Steinacker, P. & Ciesielczyk, B. et al.​ (2005) 
  Journal of Neural Transmission, 112(7) pp. 933​-948​.​ DOI: https://doi.org/10.1007/s00702-004-0235-7 
  ​Details  DOI  PMID  PMC  WoS 

• 2005 | Journal Article
  ​ ​Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease​
  Cepek, L.; Steinacker, P.; Mollenhauer, B.; Wiese, B.; Ciesielczyk, B.; Bibl, M. & Wiltfang, J. et al.​ (2005) 
  Dementia and Geriatric Cognitive Disorders, 19(5-6) pp. 376​-382​.​ DOI: https://doi.org/10.1159/000084708 
  ​Details  DOI  PMID  PMC  WoS 

• 2006 | Journal Article
  ​ ​Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies​
  Mollenhauer, B.; Bibl, M.; Wiltfang, J.; Steinacker, P.; Ciesielczyk, B.; Neubert, K. & Trenkwalder, C. et al.​ (2006) 
  Clinical Chemistry and Laboratory Medicine (CCLM), 44(2) pp. 192​-195​.​ DOI: https://doi.org/10.1515/CCLM.2006.035 
  ​Details  DOI  PMID  PMC  WoS 

• 2006 | Journal Article
  ​ ​Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia​
  Mollenhauer, B.; Trenkwalder, C.; von Ahsen, N.; Bibl, M.; Steinacker, P.; Brechlin, P. & Schindehuette, J. et al.​ (2006) 
  Dementia and Geriatric Cognitive Disorders, 22(3) pp. 200​-208​.​ DOI: https://doi.org/10.1159/000094871 
  ​Details  DOI  PMID  PMC  WoS 

• 2006 | Journal Article | Letter Note
  ​ ​Selective reduction of amyloid beta 42 discriminates Alzheimer's disease from Huntington's disease: indication for distinct pathological events in amyloid beta peptide aggregation​
  Mollenhauer, B.; Bibl, M.; Esselmann, H.; Steinacker, P.; Trenkwalder, C.; Brechlin, P. & Wiltfang, J. et al.​ (2006) 
  Journal of Neurology Neurosurgery & Psychiatry, 77(10) pp. 1201​-1203​.​ DOI: https://doi.org/10.1136/jnnp.2005.084673 
  ​Details  DOI  PMID  PMC  WoS 

• 2007 | Journal Article
  ​ ​Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: Marker candidates for dementia with Lewy bodies​
  Mollenhauer, B.; Steinacker, P.; Bahn, E.; Bibl, M.; Brechlin, P.; Schlossmacher, M. G. & Locascio, J. J. et al.​ (2007) 
  Neurodegenerative Diseases, 4(5) pp. 366​-375​.​ DOI: https://doi.org/10.1159/000105157 
  ​Details  DOI  PMID  PMC  WoS 

• 2007 | Journal Article
  ​ ​Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease​
  Cepek, L.; Brechlin, P.; Steinacker, P.; Mollenhauer, B.; Klingebiel, E.; Bibl, M. & Kretzschmar, H. A. et al.​ (2007) 
  Dementia and Geriatric Cognitive Disorders, 23(1) pp. 22​-28​.​ DOI: https://doi.org/10.1159/000096589 
  ​Details  DOI  PMID  PMC  WoS 

• 2007 | Journal Article
  ​ ​Tauopathies and synucleinopathies: Do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis?​
  Mollenhauer, B.; Bibl, M.; Esselmann, H.; Steinacker, P.; Trenkwalder, C.; Wiltfang, J. & Otto, M.​ (2007) 
  Journal of Neural Transmission, 114(7) pp. 919​-927​.​ DOI: https://doi.org/10.1007/s00702-007-0629-4 
  ​Details  DOI  PMID  PMC  WoS 

• 2008 | Journal Article
  ​ ​Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease​
  Brechlin, P.; Jahn, O. ; Steinacker, P.; Cepek, L.; Kratzin, H.; Lehnert, S. & Jesse, S. et al.​ (2008) 
  Proteomics, 8(20) pp. 4357​-4366​.​ DOI: https://doi.org/10.1002/pmic.200800375 
  ​Details  DOI  PMID  PMC  WoS 

• 2009 | Journal Article | 
  ​ ​Proteome profiling in murine models of multiple sclerosis: identification of stage specific markers and culprits for tissue damage.​
  Linker, R. A.; Brechlin, P.; Jesse, S.; Steinacker, P.; Lee, D. H.; Asif, A. R. & Jahn, O.  et al.​ (2009) 
  PLoS One, 4(10) art. e7624​.​ DOI: https://doi.org/10.1371/journal.pone.0007624 
  ​Details  DOI  PMID  PMC 

• 2010 | Journal Article | 
  ​ ​A Proteomic Approach for the Diagnosis of Bacterial Meningitis​
  Jesse, S.; Steinacker, P.; Lehnert, S.; Sdzuj, M.; Cepek, L.; Tumani, H. & Jahn, O.  et al.​ (2010) 
  PLoS One, 5(4) art. e10079​.​ DOI: https://doi.org/10.1371/journal.pone.0010079 
  ​Details  DOI  PMID  PMC  WoS 

• 2010 | Journal Article | Research Paper
  ​ ​Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis​
  Steinacker, P.; Hawlik, A.; Lehnert, S.; Jahn, O. ; Meier, S.; Görz, E. & Braunstein, K. E. et al.​ (2010) 
  The American Journal of Pathology, 176(3) pp. 1409​-1420​.​ DOI: https://doi.org/10.2353/ajpath.2010.090355 
  ​Details  DOI  PMID  PMC 

• 2011 | Journal Article | 
  ​ ​Different CSF beta-amyloid processing in Alzheimer's and Creutzfeldt-Jakob disease (vol 118, pg 691, 2011)​
  Mollenhauer, B.; Esselmann, H.; Roeber, S.; Schulz-Schaeffer, W. J.; Trenkwalder, C.; Bibl, M. & Steinacker, P. et al.​ (2011) 
  Journal of Neural Transmission, 118(8) pp. 1261​-1262​.​ DOI: https://doi.org/10.1007/s00702-011-0669-7 
  ​Details  DOI  WoS 

• 2011 | Journal Article | 
  ​ ​Different CSF beta-amyloid processing in Alzheimer's and Creutzfeldt-Jakob disease​
  Mollenhauer, B.; Esselmann, H.; Roeber, S.; Schulz-Schaeffer, W. J.; Trenkwalder, C.; Bibl, M. & Steinacker, P. et al.​ (2011) 
  Journal of Neural Transmission, 118(5) pp. 691​-697​.​ DOI: https://doi.org/10.1007/s00702-010-0543-z 
  ​Details  DOI  PMID  PMC  WoS 

• 2012 | Journal Article | Research Paper
  ​ ​Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS​
  Otto, M.; Bowser, R.; Turner, M.; Berry, J.; Brettschneider, J.; Connor, J. & Costa, J. et al.​ (2012) 
  Amyotrophic Lateral Sclerosis, 13(1) pp. 1​-10​.​ DOI: https://doi.org/10.3109/17482968.2011.627589 
  ​Details  DOI  PMID  PMC 

• 2012 | Journal Article | 
  ​ ​Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson’s Disease Dementia​
  Jesse, S.; Lehnert, S.; Jahn, O.; Parnetti, L.; Soininen, H.; Herukka, S.-K. & Steinacker, P. et al.​ (2012) 
  PLoS ONE, 7(11) art. e48783​.​ DOI: https://doi.org/10.1371/journal.pone.0048783 
  ​Details  DOI 

• 2014 | Journal Article
  ​ ​Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases​
  Feneberg, E.; Steinacker, P.; Lehnert, S.; Schneider, A.; Walther, P.; Thal, D. R. & Linsenmeier, M. et al.​ (2014) 
  Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15(5-6) pp. 351​-356​.​ DOI: https://doi.org/10.3109/21678421.2014.905606 
  ​Details  DOI  PMID  PMC  WoS 

• 2016 | Conference Abstract
  ​ ​Neurochemical markers in the differential diagnosis of primary progressive aphasias: Data from the German FTLD consortium​
  Oeckl, P.; Anderl-Straub, S.; Diehl-Schmid, J.; von Arnim, C. A. F. ; Fassbender, K.; Feneberg, E. & Fliessbach, K. et al.​ (2016)
  Journal of Neurochemistry, 138 ​10th International Conference on Frontotemporal Dementias​, Munich, GERMANY.
  Hoboken​: Wiley-blackwell.
  ​Details  WoS 

• 2021 | Journal Article
  ​ ​Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS​
  Halbgebauer, S.; Steinacker, P.; Verde, F.; Weishaupt, J.; Oeckl, P.; von Arnim, C. & Dorst, J. et al.​ (2021) 
  Journal of Neurology, Neurosurgery & Psychiatry, 93(1) pp. 68​-74​.​ DOI: https://doi.org/10.1136/jnnp-2021-327129 
  ​Details  DOI 

• 2021 | Journal Article | 
  ​ ​Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy​
  Freigang, M.; Steinacker, P.; Wurster, C. D.; Schreiber-Katz, O.; Osmanovic, A.; Petri, S. & Koch, J. C. et al.​ (2021) 
  Orphanet Journal of Rare Diseases, 16(1) art. 330​.​ DOI: https://doi.org/10.1186/s13023-021-01961-8 
  ​Details  DOI 

• 2022 | Journal Article | 
  ​ ​Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer’s and other neurodegenerative diseases​
  Halbgebauer, S.; Steinacker, P.; Riedel, D.; Oeckl, P.; Anderl-Straub, S.; Lombardi, J. & von Arnim, C. A. F. et al.​ (2022) 
  Alzheimer's Research & Therapy, 14(1).​ DOI: https://doi.org/10.1186/s13195-022-01122-4 
  ​Details  DOI 

• 2022 | Journal Article | Research Paper
  ​ ​Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion​
  Oeckl, P.; Anderl-Straub, S.; Von Arnim, C. A. F.; Baldeiras, I.; Diehl-Schmid, J.; Grimmer, T. & Halbgebauer, S. et al.​ (2022) 
  Journal of Neurology, Neurosurgery & Psychiatry,.​ DOI: https://doi.org/10.1136/jnnp-2021-328547 
  ​Details  DOI  PMID  PMC 

Researcher

Sort

Items per Page